Publications by authors named "Jason Jalil"

Claim this Profile
P
Polypharmacy in Treatment of Behavioral Issues in Dementia-Use of Atypical Antipsychotics.
Jason Jalil, Pargol Nazarian, Hans F von Walter

Clin Geriatr Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain health consequences of digital technology use
.
Gary W Small, Jooyeon Lee, Aaron Kaufman, Jason Jalil, Prabha Siddarth

Dialogues Clin Neurosci· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Promoting Strategies for the Aging Brain.
Stephen T Chen, Dax Volle, Jason Jalil, Pauline Wu, Gary W Small

Am J Geriatr Psychiatry· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer T cells in advanced melanoma patients treated with tremelimumab.
F Javier Ibarrondo, Otto O Yang, Thinle Chodon, Earl Avramis, Yohan Lee, Jason Jalil

PLoS One· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans.
Rong Rong Huang, Jason Jalil, James S Economou, Bartosz Chmielowski, Richard C Koya

Clin Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations.
Begoña Comin-Anduix, Thinle Chodon, Hooman Sazegar, Douglas Matsunaga, Stephen Mock, Jason Jalil

Clin Cancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma.
Begoña Comin-Anduix, Hooman Sazegar, Thinle Chodon, Douglas Matsunaga, Jason Jalil

PLoS One· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.
Antoni Ribas, Begoña Comin-Anduix, Bartosz Chmielowski, Jason Jalil, Pilar de la Rocha

Clin Cancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.
Erika von Euw, Thinle Chodon, Narsis Attar, Jason Jalil, Richard C Koya

J Transl Med· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade.
Antoni Ribas, Begoña Comin-Anduix, James S Economou, Timothy R Donahue, Pilar de la Rocha, Jason Jalil

Clin Cancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma.
Begoña Comin-Anduix, Yohan Lee, Jason Jalil, Alain Algazi, Pilar de la Rocha

J Transl Med· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis